Navigation Links
Transplanted liver cells function in older animals but do not proliferate as much as in younger ones
Date:4/19/2009

When things go right, transplanted healthy liver cells transplanted by infusion or injection will find their way to the liver, integrate into the damaged tissue, start proliferating, and take over the liver's work of helping with digestion and removing waste products and worn-out cells from the blood. Hepatocyte transplantation has been successful in a number of animal models, raising hopes that use of cells could overcome the shortage of donor livers and the problems of surgery, but the procedure has not been as successful in humans. Was the problem related to the age of the donor?

Now scientists at the Martin Luther University Hale-Wittenberg, Germany, believe they know the answer. Age of the donor makes no difference but age of the recipient makes a big one. Many humans requiring liver transplantation are older. The German study conducted in rats found that older rats had a repopulation rate of only 2 percent, ten times less than that seen in younger ones. Furthermore, found the scientists, the transplanted cells worked equally well in the old and young animals, as measured by glycogen storage, but the younger animals had significantly higher levels of a growth factor needed for proliferation.

The new study is the first to offer a possible mechanism for the failure of transplanted hepatocytes to proliferate in many human patients and the first to suggest a way to compensate for the problem. Dr. Peggy Stock, a postdoctoral fellow in the laboratory of Dr. Bruno Christ, reported the study on April 19 at Experimental Biology 2009 in New Orleans. The presentation was part of the scientific program of the American Society for Investigative Pathology.

The researchers isolated hepatocytes from both four week old rats (the equivalent age of a human child) and rats more than 35 weeks old (40 to 50 years in humans). These healthy liver cells were then implanted into the livers of young rats (10 weeks, the equivalent of young adulthood)
'/>"/>

Contact: Sylvia Wrobel
ebpress@gmail.com
770-722-0155
Federation of American Societies for Experimental Biology
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Circulating fats kill transplanted pancreas cells, study shows
2. Transplanted Bone Marrow Cells Aid Nerve Regeneration
3. Transplanted Liver Lining Cells May Cure Hemophilia
4. New approaches to protecting transplanted organs make first steps toward patients
5. Transplanted fatty livers associated with worse prognosis for patients with HCV
6. Advanced Age No Bar to Liver Transplant
7. Researchers Find Better Way to Deliver Blood Thinner
8. Federal research plan to determine nanotech risks fails to deliver
9. Liver cancer marker could yield blood test for early detection
10. Blood Marker Might Help Spot Early Liver Cancer
11. Natural Protein Could Help Spot, Treat Liver Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... FRIDAY, May 17 (HealthDay News) -- It comes as little ... shows that college women are more likely to drink unhealthy ... men. Much of this difference is probably because ... basis is much lower for women than it is for ... there,s good reason for that difference. Women don,t metabolize alcohol ...
(Date:5/18/2013)... TheBeautyPlace.com answers important questions about the hairloss products ... result of stress, nutrient deficiency or wearing a favorite ... men suffer from male patterned baldness. , ... transplant surgery, but additionally carries a hair care product ... Professional Strength. Their product line is a five-step treatment ...
(Date:5/18/2013)... During Better Hearing and Speech Month, parents ... protections they have, including the right to bring a ... treatment or hearing aid device, attorney Ronald E. Johnson ... Association has used the month of May to raise ... as cochlear implants, which can improve the quality of ...
(Date:5/18/2013)... The “Sleep Apnea Diagnostic & Therapeutic Devices Market ... (ASV), Oral Appliances, Nasal EPAP, Neurostimulation] Global End-user Analysis, ... the major market drivers, restraints, and opportunities in North ... Browse , 147 market data ... 318 pagesand in-depth TOC of “Sleep ...
(Date:5/18/2013)... Show And Go Training, the culmination of Eric ... that is all about is getting results in the fastest ... http://ShowAndGoTrainingReview.com ’s Stan Stevenson, prompting an investigative review. , ... phase system” designed to make you faster, stronger, fitter and ... out in the gym. The training manual and exercise video ...
Breaking Medicine News(10 mins):Health News:College Women More Prone to Problem Drinking Than Men: Study 2Health News:College Women More Prone to Problem Drinking Than Men: Study 3Health News:TheBeautyPlace.com Features the Two New Best-Selling Hairloss Products: Bosley Professional Strength and Nioxin Systems 2Health News:TheBeautyPlace.com Features the Two New Best-Selling Hairloss Products: Bosley Professional Strength and Nioxin Systems 3Health News:Schachter, Hendy & Johnson PSC Lawyer Says Cochlear Implant Victims Should Know Their Legal Rights 2Health News:Schachter, Hendy & Johnson PSC Lawyer Says Cochlear Implant Victims Should Know Their Legal Rights 3Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 2Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 3Health News:Show And Go Training: Review Examining Eric Cressy's Workout Program Revealed 2
... Health Information System via Remote Hosting Services to Improve ... , CINCINNATI, Dec. 9 Streamline ... announced that it will integrate its enterprise document ... of Massena Memorial Hospital, a leading quality health care ...
... , The following ... Recently there has been a ... our healthcare delivery system. We are told there are 46 ... are,calling for immediate government intervention with a nationalized healthcare,rescue plan ...
... Real-Time Linking to Lexi-Comp Drug Resources for Mutual Subscribers ... ... 2008 -- Institutions subscribing to DynaMed™ , or other ... able to seamlessly access real-time information from their Lexi-Comp ...
... over but Australian champion runner Craig Mottram had one more challenge to ... ... (PRWEB) December 9, 2008 -- The historic inaugural HBA Great Australian Run ... challenge to complete. , , , , ,Mottram, who was competing ...
... Cell Therapeutics, Inc.,(Nasdaq and MTA: CTIC) announced today ... ([90Y]-ibritumomab tiuxetan) were,presented at the American Society of Hematology ... In one presentation, the ... the use of single dose Zevalin as sole initial ...
... PLEASANTON, Calif., Dec. 8 Roche Molecular Diagnostics,announced today ... new,COBAS(R) AmpliPrep / COBAS(R) TaqMan(R) HBV Test v2.0, allowing ... Union. This highly sensitive test offers,Roche,s fully automated ... the quantitative detection of hepatitis B virus (HBV) DNA ...
Cached Medicine News:Health News:Streamline Health(R) Announces Massena Memorial Hospital to Implement Enterprise Document Workflow Solutions 2Health News:Streamline Health(R) Announces Massena Memorial Hospital to Implement Enterprise Document Workflow Solutions 3Health News:Streamline Health(R) Announces Massena Memorial Hospital to Implement Enterprise Document Workflow Solutions 4Health News:Streamline Health(R) Announces Massena Memorial Hospital to Implement Enterprise Document Workflow Solutions 5Health News:Average Americans Without Health Insurance Are Young and Healthy With Above Average Incomes 2Health News:EBSCO Publishing and Lexi-Comp Formalize Product Partnership to Enable Seamless Integration Between Products 2Health News:EBSCO Publishing and Lexi-Comp Formalize Product Partnership to Enable Seamless Integration Between Products 3Health News:EBSCO Publishing and Lexi-Comp Formalize Product Partnership to Enable Seamless Integration Between Products 4Health News:Mottram Honours His End of the HBA Great Australian Run challenge 2Health News:Three Italian Multicenter Studies Report High (>70%) Rates of Complete Remission (CR) Utilizing Zevalin Radio-Immunotherapy (RIT) in Treatment of Newly Diagnosed or Relapsed or Refractory Non-Hodgkin's Lymphoma 2Health News:Three Italian Multicenter Studies Report High (>70%) Rates of Complete Remission (CR) Utilizing Zevalin Radio-Immunotherapy (RIT) in Treatment of Newly Diagnosed or Relapsed or Refractory Non-Hodgkin's Lymphoma 3Health News:Three Italian Multicenter Studies Report High (>70%) Rates of Complete Remission (CR) Utilizing Zevalin Radio-Immunotherapy (RIT) in Treatment of Newly Diagnosed or Relapsed or Refractory Non-Hodgkin's Lymphoma 4Health News:Three Italian Multicenter Studies Report High (>70%) Rates of Complete Remission (CR) Utilizing Zevalin Radio-Immunotherapy (RIT) in Treatment of Newly Diagnosed or Relapsed or Refractory Non-Hodgkin's Lymphoma 5Health News:Improved Testing for Hepatitis B Virus From Roche 2Health News:Improved Testing for Hepatitis B Virus From Roche 3
(Date:5/16/2013)... SOUTH PLAINFIELD, N.J. , May 16, 2013 /PRNewswire/ ... a registration statement on Form S-1 with the U.S. ... initial public offering of its common stock. The number ... for the offering have not been determined. ... and Credit Suisse are acting as joint book-running managers ...
(Date:5/16/2013)... Mass. and SYDNEY , May ... - ASX: HIN), a leading innovator of less invasive, ... advanced heart failure, today announced that CEO Doug ... UBS Global Healthcare Conference at 11:00 a.m. EDT on Monday, ... 2013 at the Sheraton New York Hotel. A ...
(Date:5/16/2013)... , May 16, 2013 AcelRx Pharmaceuticals, Inc. (Nasdaq: ... the development and commercialization of innovative therapies for the treatment ... Richard King , President and CEO, will present a ... Sheraton New York Hotel in New York ... 2013 at 9:30 a.m. ET/6:30 a.m. PT. The ...
Breaking Medicine Technology:PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast 2AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference 2AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference 3
... N.Y., Dec. 1, 2011  Regeneron Pharmaceuticals, Inc. (Nasdaq: ... Company,s presentation at the 2011 Deutsche Bank BioFEST scheduled ... for 1:05 p.m. Eastern Time.  The session may be ... on the Investor Relations page.  An archived version of ...
... Ill., Dec. 1, 2011   Sysmex America, Inc., a global ... technology, today announces that the company has been named ... 100 Best Places to Work in Healthcare , ranking ... overall.  Results were based on company application and employee ...
Cached Medicine Technology:Regeneron Announces Presentation Time Change at the 2011 Deutsche Bank BioFEST 2Sysmex America Earns Spot on Top 100 Best Places to Work in Healthcare 2Sysmex America Earns Spot on Top 100 Best Places to Work in Healthcare 3
Weitlaner-Locktite retractors, blunt, 11 cm total length....
Weitlaner Beckmann retractor, sharp prongs, SS....
Weitlaner retractor, blunt....
Daubenspeck sharp curette, 8....
Medicine Products: